(NU/1433-37) NewCo: The Provision of Business Consultancy to Assist Commercialisation of University Research.

Award

Value

£30,000

Classifications

  • Business and management consultancy and related services

Tags

  • award
  • contract

Published

2 years ago

Description

Cancer and neurodegenerative diseases represent major unmet medical needs. It is estimated that approximately 20% of oncogenes are transcription factors (TFs) and many are critical for carcinogenesis. The global Cancer Drugs market was valued at US$92Bn in 2019 and is expected to reach US$124Bn by the end of 2026. The global neurodegenerative diseases drugs market size was valued at US$35.5Bn Million in 2018 and is projected to reach US$63Bn by the end of 2026. Specifically, we plan to target three cancer related TFs, (ATF4 CREB, and ID1) which are implicated in a range of cancer types that include glioma, breast cancer, acute myeloid leukaemia, and the aggregation of a-synuclein and amyloid implicated in Parkinson's Disease and Alzheimer's disease respectively.
The initial brief of the executive will be to:
Phase (1) September 2022 - December 2022 - Work with Jody Mason and Uni TT team to review current targets, oversee screening programme and lead candidates and produce a viable 5-year business plan and associated pitch deck;
Phase (2)September 2022 - December 2022 - Navigate University approval process, work with TT team to get approval from the University Commercialisation Executive Board
Phase (3) January 2023-March 2023 – a. Act for the company in the spin out legal process and review the Articles of Association, Shareholder's agreement and IP licence put together by the University;
b. Work with the Unit TT team to obtain founder academics’ and University approval for appointment as CEO.
c. Provide to the University of Bath all matters necessary for Research England reporting requirements.
Phase (4) January 2023-June 2023 - Pitch to investors alongside Jody Mason, secure seed finance, draft and submit Innovate UK proposal for preclinical funding
Phase (5) The outcome of Phase 4 will provide seed finance and IUK funding for preclinical studies, which will be sufficient to employ the executive and drive preclinical development. The appointment of the executive as CEO will be at the discretion of the board and the University of Bath and will be subject to confirmation, typically at Stage 4 above.

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download
  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

Open

Provision of Internal Audit and Advisory Services (Cross Council Assurance Services)

The London Borough of Barnet wishes to commission the provision of Internal Audit and Advisory services by establishing a framework agreement under two lots. The Council is seeking multiple service providers (Suppliers) to establish two (2) multiple provider lots under a framework agreement on its behalf for an initial three (3) year period from 1 April 2026 to 31 March 2029 with the option to extend for a further five (5) years to 31 March 2034, subject to budget constraints and performance. This framework is intended to operate as an open framework. At the end of the initial three-year period (March 2029), the Authority will conduct a review of supplier engagement through the framework. This review will consider both pricing and performance to determine whether the framework should be opened to extension and enable additional supplier entrants. The criteria and trigger for opening the framework will be developed in consultation with the Authority’s Legal team and Procurement service. This will be communicated to all qualified suppliers on the framework in advance of the review and will be subject to release of appropriate Find a Tender Service notice. Full detail of this requirement including known risk are identified in the tender documents which can be access from https://londonbarnet.delta-esourcing.com/ The Framework is available to Public funded organisations: local authorities https://www.gov.uk/find-local-council Mayoral Combined Authorities Combined authorities | Local Government Association Greater London Authority Group https://www.london.gov.uk/ London Fire & Emergency Planning Authority https://www.london-fire.gov.uk/ Transport for London https://tfl.gov.uk/ Mayor's Office for Policing and Crime https://www.london.gov.uk/programmes-strategies/mayors-office-policing-and-crime-mopac London Legacy Development Corporation https://www.queenelizabetholympicpark.co.uk/legacy-corporation GLA Family London & Partners https://www.londonandpartners.com/ London TravelWatch https://www.londontravelwatch.org.uk/ London Pensions Fund Authority https://www.lpfa.org.uk/ London Waste & Recycling Board https://relondon.gov.uk/about-us Museum of London https://www.londonmuseum.org.uk/ His Majesty's Inspectorate of Constabulary & Fire & Rescue Services Health Authorities Councils Boards, Trusts NHS England, NHS provider directory Registered list of social housing List of registered providers - 16 May 2025 accessible version-GOV.UK Tenant Management Organisations https://nftmo.com/about-the-nftmo/membership-2024/ Arm's Length Management Organisations https://www.almos.org.uk/about-us/our-members/ Higher Education Universities and higher education - GOV.UK Charities https://register-of-charities.charitycommission.gov.uk/en/ For more information about this opportunity, please visit the Delta eSourcing portal at: https://londonbarnet.delta-esourcing.com/tenders/UK-UK-Colindale:-Business-analysis-consultancy-services./F55Q57G779 To respond to this opportunity, please click here: https://londonbarnet.delta-esourcing.com/respond/F55Q57G779

Katy Reed

Published 6 hours ago

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete

Publish
Bid
Evaluate
Award
Complete